Effects of Monotherapy of Temocapril or Candesartan with Dose Increments or Combination Therapy with Both Drugs on the Suppression of Diabetic Nephropathy
“…Further studies by Rossing et al (26) demonstrated that the antiproteinuric effect of irbesartan at ultrahigh dosage (900 mg once daily) was superior to the usual recommended dose (300 mg) in hypertensive type 2 diabetic patients. Similar results were also reported by Ogawa et al (7) who showed that candesartan's effects on albuminuria were dose-dependent in Japanese hypertensive type 2 diabetic patients. However, in the present study, the dose-dependent effects of telmisartan at 40 and 80 mg on UACR were not observed in hypertensive patients.…”
Section: Discussionsupporting
confidence: 90%
“…3B). Thus, it is possible that during angiotensin blockade with telmisartan, there is an important relationship between blood pressure reduction and reduction in albuminuria in hypertensive type 2 diabetic patients, as suggested by other clinical studies (7,24,25).…”
Section: Discussionmentioning
confidence: 86%
“…In the present study, over 70% of hypertensive patients were treated with CCBs, whereas previous studies used a washout period of a few weeks to eliminate all antihypertensive medications, or their subjects were previously untreated moderate hypertensive patients (6,7,26). Other possibilities cannot be ruled out and need to be examined further.…”
Section: Discussionmentioning
confidence: 86%
“…31 (2008) , Masakazu HANEDA 2) , Tetsuya BABAZONO 3) , Tatsumi MORIYA 4) , Sadayoshi ITO 5) , Yasuhiko IWAMOTO 6) , Ryuzo KAWAMORI 7) , Masahiro TAKEUCHI 8) , and Shigehiro KATAYAMA 9) , for the INNOVATION Study Group…”
“…Further studies by Rossing et al (26) demonstrated that the antiproteinuric effect of irbesartan at ultrahigh dosage (900 mg once daily) was superior to the usual recommended dose (300 mg) in hypertensive type 2 diabetic patients. Similar results were also reported by Ogawa et al (7) who showed that candesartan's effects on albuminuria were dose-dependent in Japanese hypertensive type 2 diabetic patients. However, in the present study, the dose-dependent effects of telmisartan at 40 and 80 mg on UACR were not observed in hypertensive patients.…”
Section: Discussionsupporting
confidence: 90%
“…3B). Thus, it is possible that during angiotensin blockade with telmisartan, there is an important relationship between blood pressure reduction and reduction in albuminuria in hypertensive type 2 diabetic patients, as suggested by other clinical studies (7,24,25).…”
Section: Discussionmentioning
confidence: 86%
“…In the present study, over 70% of hypertensive patients were treated with CCBs, whereas previous studies used a washout period of a few weeks to eliminate all antihypertensive medications, or their subjects were previously untreated moderate hypertensive patients (6,7,26). Other possibilities cannot be ruled out and need to be examined further.…”
Section: Discussionmentioning
confidence: 86%
“…31 (2008) , Masakazu HANEDA 2) , Tetsuya BABAZONO 3) , Tatsumi MORIYA 4) , Sadayoshi ITO 5) , Yasuhiko IWAMOTO 6) , Ryuzo KAWAMORI 7) , Masahiro TAKEUCHI 8) , and Shigehiro KATAYAMA 9) , for the INNOVATION Study Group…”
“…Reducing BP is known to decrease ACR (39). In the present study, greater reductions of BP were associated with greater decreases in ACR in both the AZ and NF group.…”
Section: Fig 2 the Correlation Between The % Change Of Blood Pressusupporting
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.